Cardiovascular disease in Europe: epidemiological update 2016.
By N. Townsend, L. Wilson, P. Bhatnagar, K. Wickramasinghe, M. Rayner, Melanie Nichols. European Heart Journal, 2016
1,472 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Organizational Behavior and Human Resource Management, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/d1d41f5b583a1ef5df6988344c0e73a5a5fec576
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Organizational Behavior and Human Resource Management
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Coarse race data conceals disparities in clinical risk score performance (2023, result): “, 2013; NYC, 2022) and heart failure in Russian patients (Townsend et al., 2016)—also align with existing literature.”
- Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress (2021, background): “In China, Europe, the United States and other developed countries, the incidence and mortality of CVD rank first [3,4].”
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, background): “8 million annual deaths, or 20% of all deaths in Europe, although with large variations between countries.(14)”
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019, background): “193 000).(3) Prevention is defined as a co-ordinated set of actions, either at the population or individual level, aimed at eliminating or minimizing the impact of CV diseases and their related disabilities.”